Commercial announcements are coming thick and fast from OptiBiotix Health plc (LON:OPTI), which is developing natural remedies for obesity, cholesterol and weight loss.
In its third update in a week, the company said it had agreed on a non-exclusive deal with the privately-owned functional foods business CTC Group, which will distribute weight management product SlimBiome in the Philippines, Vietnam, Indonesia and Colombia.
READ: OptiBiotix Health inks Bulgarian deal for cholesterol product
“This extends our commercialisation of SlimBiome into ASEAN [the Association of South Asian Nations] markets where we have identified a strong consumer need for both weight loss and weight management products,” said OptiBiotix sales and market director, Christina Wood.
The deal follows hard on the heels of a distribution agreement for its cholesterol product, CholBiome, and news that the group plans to spin out ProBiotix business.
OptiBiotix is a pioneer of the human microbiome, which is essentially the bacteria that inhabit the gut and skin.
It has found, for instance, small changes in the gut flora can affect the way the human body processes food.